VAT expansion increases proinflammatory cytokines (e.g., interleukin-6 [IL-6], tumor necrosis factor-alpha [TNF-α]), driving insulin resistance [15, 16], and reduces adiponectin, exacerbating metabolic dysregulation [17]. The gene discussed is IL6; the disease is Insulin resistance.